Reporting Manager
venBio Global Strategic Fund IV, L.P.
Symbol
ALMS
Shares outstanding
96,245,896 shares
Disclosed Ownership
4,619,803 shares
Ownership
4.8%
Form type
SCHEDULE 13G/A
Filing time
17 Nov 2025, 13:13:11 UTC
Date of event
30 Jun 2025

Sponsored

Quoteable Key Fact

"venBio Global Strategic Fund IV, L.P. disclosed 4.8% ownership in ALUMIS INC. Common Stock, $0.0001 par value per share (ALMS) on 30 Jun 2025."

Quick Takeaways

  • venBio Global Strategic Fund IV, L.P. filed SCHEDULE 13G/A for ALUMIS INC. Common Stock, $0.0001 par value per share (ALMS).
  • Disclosed ownership: 4.8%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Nov 2025, 13:13.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
venBio Global Strategic Fund IV, L.P. 4.8% 4,619,803 0 4,619,803 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Members of the General Partner
venBio Global Strategic GP IV, LLC 4.8% 4,619,803 0 4,619,803 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Members
Adelman Robert J 4.8% 4,619,803 0 4,619,803 /s/ David Pezeshki David Pezeshki, as attorney-in-fact
GOODMAN COREY S 4.8% 4,619,803 0 4,619,803 /s/ David Pezeshki David Pezeshki, as attorney-in-fact